Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Two Hypervirulent Klebsiella pneumoniae Isolates Producing a bla KPC-2 Carbapenemase from a Canadian Patient.

Mataseje LF, Boyd DA, Mulvey MR, Longtin Y.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00517-19. doi: 10.1128/AAC.00517-19. Print 2019 Jul.

PMID:
30988151
2.

Results from the Canadian Nosocomial Infection Surveillance Program for detection of carbapenemase-producing Acinetobacter spp. in Canadian hospitals, 2010-16.

Boyd DA, Mataseje LF, Pelude L, Mitchell R, Bryce E, Roscoe D, Embree J, Katz K, Kibsey P, Lavallee C, Simor AE, Taylor G, Turgeon N, Langley JM, Amaratunga K, Mulvey MR; Canadian Nosocomial Infection Surveillance Program .

J Antimicrob Chemother. 2019 Feb 1;74(2):315-320. doi: 10.1093/jac/dky416.

PMID:
30312401
3.

Characterization of OXA-48-like carbapenemase producers in Canada, 2011-14.

Mataseje LF, Boyd DA, Fuller J, Haldane D, Hoang L, Lefebvre B, Melano RG, Poutanen S, Van Caeseele P, Mulvey MR.

J Antimicrob Chemother. 2018 Mar 1;73(3):626-633. doi: 10.1093/jac/dkx462.

PMID:
29272439
4.

Enterobacter cloacae Complex Isolates Harboring blaNMC-A or blaIMI-Type Class A Carbapenemase Genes on Novel Chromosomal Integrative Elements and Plasmids.

Boyd DA, Mataseje LF, Davidson R, Delport JA, Fuller J, Hoang L, Lefebvre B, Levett PN, Roscoe DL, Willey BM, Mulvey MR.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02578-16. doi: 10.1128/AAC.02578-16. Print 2017 May.

5.

Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.

Mataseje LF, Abdesselam K, Vachon J, Mitchel R, Bryce E, Roscoe D, Boyd DA, Embree J, Katz K, Kibsey P, Simor AE, Taylor G, Turgeon N, Langley J, Gravel D, Amaratunga K, Mulvey MR.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6787-6794. doi: 10.1128/AAC.01359-16. Print 2016 Nov.

6.

Dissemination of the mcr-1 colistin resistance gene.

Mulvey MR, Mataseje LF, Robertson J, Nash JH, Boerlin P, Toye B, Irwin R, Melano RG.

Lancet Infect Dis. 2016 Mar;16(3):289-90. doi: 10.1016/S1473-3099(16)00067-0. No abstract available.

PMID:
26973304
7.

New Delhi metallo-β-lactamase in Jamaica.

Thoms-Rodriguez CA, Mazzulli T, Christian N, Willey BM, Boyd DA, Mataseje LF, Mulvey MR, Christie CD, Nicholson AM.

J Infect Dev Ctries. 2016 Feb 28;10(2):183-7. doi: 10.3855/jidc.7094.

8.

Colistin-Nonsusceptible Pseudomonas aeruginosa Sequence Type 654 with blaNDM-1 Arrives in North America.

Mataseje LF, Peirano G, Church DL, Conly J, Mulvey M, Pitout JD.

Antimicrob Agents Chemother. 2016 Jan 11;60(3):1794-800. doi: 10.1128/AAC.02591-15.

9.

Serratia marcescens harbouring SME-type class A carbapenemases in Canada and the presence of blaSME on a novel genomic island, SmarGI1-1.

Mataseje LF, Boyd DA, Delport J, Hoang L, Imperial M, Lefebvre B, Kuhn M, Van Caeseele P, Willey BM, Mulvey MR.

J Antimicrob Chemother. 2014 Jul;69(7):1825-9. doi: 10.1093/jac/dku040. Epub 2014 Mar 21.

PMID:
24659751
10.

Complete sequences of a novel blaNDM-1-harbouring plasmid from Providencia rettgeri and an FII-type plasmid from Klebsiella pneumoniae identified in Canada.

Mataseje LF, Boyd DA, Lefebvre B, Bryce E, Embree J, Gravel D, Katz K, Kibsey P, Kuhn M, Langley J, Mitchell R, Roscoe D, Simor A, Taylor G, Thomas E, Turgeon N, Mulvey MR; Canadian Nosocomial Infection Surveillance Program.

J Antimicrob Chemother. 2014 Mar;69(3):637-42. doi: 10.1093/jac/dkt445. Epub 2013 Nov 24.

PMID:
24275114
11.

Carbapenem-hydrolyzing oxacillinase-48 and oxacillinase-181 in Canada, 2011.

Mataseje LF, Boyd DA, Hoang L, Imperial M, Lefebvre B, Miller M, Poutanen SM, Roscoe D, Willey BM, Mulvey MR.

Emerg Infect Dis. 2013 Jan;19(1):157-60. doi: 10.3201/eid1901.120706. No abstract available.

12.

Characterization of Escherichia coli urinary tract infection isolates in remote northern Saskatchewan communities: the Northern Antibiotic Resistance Partnership.

Golding GR, Persaud N, Levett PN, McDonald RR, Irvine J, Nsungu M, Woods S, Khan M, Mataseje LF, Mulvey MR; Northern Antibiotic Resistance Partnership.

Diagn Microbiol Infect Dis. 2012 Nov;74(3):242-7. doi: 10.1016/j.diagmicrobio.2012.07.003. Epub 2012 Sep 1.

PMID:
22944458
13.

Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP).

Mataseje LF, Bryce E, Roscoe D, Boyd DA, Embree J, Gravel D, Katz K, Kibsey P, Kuhn M, Mounchili A, Simor A, Taylor G, Thomas E, Turgeon N, Mulvey MR; Canadian Nosocomial Infection Surveillance Program.

J Antimicrob Chemother. 2012 Jun;67(6):1359-67. doi: 10.1093/jac/dks046. Epub 2012 Mar 7.

PMID:
22398651
14.

Plasmid comparison and molecular analysis of Klebsiella pneumoniae harbouring bla(KPC) from New York City and Toronto.

Mataseje LF, Boyd DA, Willey BM, Prayitno N, Kreiswirth N, Gelosia A, Poutanen SM, Low DE, Jenkins SG, Katz K, Mulvey MR.

J Antimicrob Chemother. 2011 Jun;66(6):1273-7. doi: 10.1093/jac/dkr092. Epub 2011 Mar 15.

PMID:
21406433
15.

Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.

McCracken M, Mataseje LF, Loo V, Walkty A, Adam HJ, Hoban DJ, Zhanel GG, Mulvey MR; Canadian Antimicrobial Resistance Alliance (CARA).

Diagn Microbiol Infect Dis. 2011 Mar;69(3):335-41. doi: 10.1016/j.diagmicrobio.2010.10.030.

PMID:
21353962
16.

Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007-2009 study.

Nichol KA, Adam HJ, Hussain Z, Mulvey MR, McCracken M, Mataseje LF, Thompson K, Kost S, Lagacé-Wiens PR, Hoban DJ, Zhanel GG; Canadian Antimicrobial Resistance Alliance (CARA).

Diagn Microbiol Infect Dis. 2011 Mar;69(3):320-5. doi: 10.1016/j.diagmicrobio.2010.10.028.

PMID:
21353960
17.

Comparison of CMY-2 plasmids isolated from human, animal, and environmental Escherichia coli and Salmonella spp. from Canada.

Mataseje LF, Baudry PJ, Zhanel GG, Morck DW, Read RR, Louie M, Mulvey MR.

Diagn Microbiol Infect Dis. 2010 Aug;67(4):387-91. doi: 10.1016/j.diagmicrobio.2010.02.027.

PMID:
20638610
18.

Characterization of Canadian cefoxitin-resistant non-typhoidal Salmonella isolates, 2005-06.

Mataseje LF, Xiao J, Kost S, Ng LK, Doré K, Mulvey MR; Canadian Public Health Laboratory Network (CPHLN).

J Antimicrob Chemother. 2009 Oct;64(4):723-30. doi: 10.1093/jac/dkp249. Epub 2009 Jul 27.

PMID:
19638354
19.

Characterization of cefoxitin-resistant Escherichia coli isolates from recreational beaches and private drinking water in Canada between 2004 and 2006.

Mataseje LF, Neumann N, Crago B, Baudry P, Zhanel GG, Louie M, Mulvey MR; ARO Water Study Group.

Antimicrob Agents Chemother. 2009 Jul;53(7):3126-30. doi: 10.1128/AAC.01353-08. Epub 2009 Apr 27.

Supplemental Content

Loading ...
Support Center